Type 1 diabetes

• A first-in-human clinical trial using a gene therapy with patient’s own stem cells to treat early type 1 diabetes Recruiting
  2025-521304-21-00 7 2026-03-13
• Bioavailability, Biopotency and Food effect study of SCD0503 compared to subcutaneous regular human insulin Recruiting
  2024-519502-12-00 1 2026-05-29
• SAFEGUARD (SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes) Study Recruiting
  2025-521560-36-00 4 2026-04-22
• The effect of colchicine, on insulin sensitivity in individuals with type 1 diabetes and systemic low-grade inflammation (INS1GHT) Recruiting
  2025-522528-29-00 4 2025-12-22
• Anti-inflammatory drug to prevent complications in type 1 diabetes Recruiting
  2025-521397-34-00 11 2025-12-15
• A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination wi … Recruiting
  2024-519945-31-00 5 2025-08-21
• A Phase I/II Double-blind, randomized, placebo-controlled trial to preserve residual insulin secretion in children with recent onset Type 1 … Recruiting
  2024-515106-30-00 9 2025-08-06
• Tolerogenic dendritic cell therapy in type 1 diabetes; a phase 1b safety and immunological effecitivity study Recruiting
  2023-508558-25-01 9 2024-12-02
• WJMSC-P01 Recruiting
  2024-518270-14-00 4 2024-11-12
• New treatments to reduce cardiovascular disease in type 1 diabetes Recruiting
  2023-505794-32-04 5 2024-07-05
• Grafalon®therapy within 12 weeks of Type 1 diabetes (T1D) diagnosis in children and young adults to prevent the loss of residual beta cell f … Recruiting
  2023-508514-42-00 4 2024-06-04
• INVITED trial Recruiting
  2022-500906-17-01 4 2023-03-21
• Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes (REC1TE): a randomized, double-blind, placebo-controll … Recruitment ended
  2022-502038-23-00 4 2023-08-25
• Premixed glucagon/insulin solution for faster insulin absorption in Type 1 diabetes. Halted
  2023-510408-32-02 4 2025-04-01
• Fast-Acting Insulins and Their Post-Meal Effects in Type 1 Diabetes Ended
  2023-509217-37-00 3 2024-06-25

Showing 1–15 of 15 trials